TY  - GEN
AU  - Bostwick,D G
AU  - Burke,H B
AU  - Wheeler,T M
AU  - Chung,L W
AU  - Bookstein,R
AU  - Pretlow,T G
AU  - Nagle,R B
AU  - Montironi,R
AU  - Lieber,M M
AU  - Veltri,R W
TI  - The most promising surrogate endpoint biomarkers for screening candidate chemopreventive compounds for prostatic adenocarcinoma in short-term phase II clinical trials
SN  - 0733-1959
PY  - 1995///0210
KW  - Anticarcinogenic Agents
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Clinical Trials, Phase II as Topic
KW  - DNA, Neoplasm
KW  - Humans
KW  - Male
KW  - Mass Screening
KW  - Neovascularization, Pathologic
KW  - Ploidies
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - Prostate-Specific Antigen
KW  - Prostatic Neoplasms
KW  - blood
KW  - Receptor, ErbB-2
N1  - Publication Type: Consensus Development Conference; Journal Article; Review
ER  -